News
-
-
-
COMMUNIQUÉ DE PRESSE
PharmaSGP with strong revenues growth in 9M 2024 – revenues forecast for FY 2024 raised
PharmaSGP Holding SE reports strong revenue growth in 9 months of 2024, with preliminary figures showing a 17.0% increase compared to the same period last year. FY 2024 revenue forecast raised -
-
-
COMMUNIQUÉ DE PRESSE
adesso shows stronger profitability in the third quarter and increases operating result after nine months by 24 % to EUR 66.5 million / Sales revenues grow by 15 % to EUR 961.3 million
adesso SE reports 24% increase in operating result after nine months to EUR 66.5 million, with sales revenues growing by 15% to EUR 961.3 million, driven by strong demand for digitalisation services -
COMMUNIQUÉ DE PRESSE
Dermapharm Holding SE posts strong results for Q3 2024, Arkopharma (France) back above prior-year EBITDA levels for first time
Dermapharm Holding SE reports strong Q3 2024 results with consolidated revenue up 2.7% to EUR 890.1 million. Adjusted EBITDA margin improves. Outlook confirms forecasted targets for 2024 -
COMMUNIQUÉ DE PRESSE
Energiekontor AG: Energiekontor consequently drives forward 2023 to 2028 growth strategy and plans to sell several more projects by end of the year
Energiekontor drives forward 2023-2028 growth strategy, plans to sell more projects by year-end. First 9 months of 2024 show positive operating performance & project pipeline development -
COMMUNIQUÉ DE PRESSE
Mister Spex SE Reports 2% Growth in Core German Market and Significant Improvement in Gross Margin in Q3 2024 – Guidance for 2024 confirmed
Mister Spex SE reports 2% growth in core German market and significant improvement in gross margin in Q3 2024. Revenue reached €57.8 million with a 3% decline due to international store closures -
